BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9661634)

  • 1. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.
    Watanabe T; Bai M; Lane CR; Matsumoto S; Minamitani K; Minagawa M; Niimi H; Brown EM; Yasuda T
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2497-502. PubMed ID: 9661634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.
    Nagase T; Murakami T; Tsukada T; Kitamura R; Chikatsu N; Takeo H; Takata N; Yasuda H; Fukumoto S; Tanaka Y; Nagata N; Yamaguchi K; Akatsu T; Yamamoto M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2681-7. PubMed ID: 12050233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptor.
    De Luca F; Ray K; Mancilla EE; Fan GF; Winer KK; Gore P; Spiegel AM; Baron J
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2710-5. PubMed ID: 9253358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
    Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
    J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
    Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
    J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.
    Pearce SH; Williamson C; Kifor O; Bai M; Coulthard MG; Davies M; Lewis-Barned N; McCredie D; Powell H; Kendall-Taylor P; Brown EM; Thakker RV
    N Engl J Med; 1996 Oct; 335(15):1115-22. PubMed ID: 8813042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia.
    Baran N; ter Braak M; Saffrich R; Woelfle J; Schmitz U
    Mol Cell Endocrinol; 2015 May; 407():18-25. PubMed ID: 25766501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of the Ca2+-sensing receptor.
    Mancilla EE; De Luca F; Baron J
    Mol Genet Metab; 1998 Jul; 64(3):198-204. PubMed ID: 9719629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor.
    Tan YM; Cardinal J; Franks AH; Mun HC; Lewis N; Harris LB; Prins JB; Conigrave AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):605-10. PubMed ID: 12574188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.
    Sato K; Hasegawa Y; Nakae J; Nanao K; Takahashi I; Tajima T; Shinohara N; Fujieda K
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3068-73. PubMed ID: 12107202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene.
    Yamauchi M; Sugimoto T; Yamaguchi T; Yano S; Wang J; Bai M; Brown EM; Chihara K
    J Bone Miner Res; 2002 Dec; 17(12):2174-82. PubMed ID: 12469911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor.
    Hu J; Mora S; Weber G; Zamproni I; Proverbio MC; Spiegel AM
    J Bone Miner Res; 2004 Apr; 19(4):578-86. PubMed ID: 15005845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene.
    Hendy GN; Minutti C; Canaff L; Pidasheva S; Yang B; Nouhi Z; Zimmerman D; Wei C; Cole DE
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3674-81. PubMed ID: 12915654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial hypoparathyroidism due to activating mutations in the calcium-sensing receptor gene].
    Watanabe T; Minagawa M
    Nihon Rinsho; 2002 Feb; 60(2):331-7. PubMed ID: 11857922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia.
    Conley YP; Finegold DN; Peters DG; Cook JS; Oppenheim DS; Ferrell RE
    Mol Genet Metab; 2000 Dec; 71(4):591-8. PubMed ID: 11136551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gain-of-function mutation (F821L) in the transmembrane domain of calcium-sensing receptor is a cause of severe sporadic hypoparathyroidism.
    Shiohara M; Mori T; Mei B; Brown EM; Watanabe T; Yasuda T
    Eur J Pediatr; 2004 Feb; 163(2):94-8. PubMed ID: 14677060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ca(2+)-sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to Ca2+ and maximal signal transduction.
    Mancilla EE; De Luca F; Ray K; Winer KK; Fan GF; Baron J
    Pediatr Res; 1997 Oct; 42(4):443-7. PubMed ID: 9380434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia.
    Lienhardt A; Garabédian M; Bai M; Sinding C; Zhang Z; Lagarde JP; Boulesteix J; Rigaud M; Brown EM; Kottler ML
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1695-702. PubMed ID: 10770217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.